The Danger Has Been Known for About 13 Years Contrary
to various claims, knowledge of the devastating damage that anti-cholesterol
drugs can have on human muscle cells is nothing new to the pharmaceutical
industry.
Quite the contrary: the pharmaceutical industry has known for at least
12 years that anti-cholesterol drugs impair the synthesis in the human
body of the vital Coenzyme Q10.
This has devastating consequences, and not only for the optimum functioning
of cells in human muscle tissue.
Coenzyme Q10 is a vital bio-energy substance, which is of central importance
for the optimum functioning of the human heart and cardiovascular system.
Once again, a pharmaceutical drug has been revealed as contributing to
precisely the disease for which it is being prescribed to millions of
people!
It has also been known for years that the simultaneous prescription
of Coenzyme Q10 (CoQ10) and anti-cholesterol drugs can at least partially
counteract these side effects. Since 1989 the pharmaceuticals giant Merck
has held US
Patent No. 4,933,165 for the addition of the vital bio-energy
substance CoQ10 to its anti-cholesterol drugs lovastatin, simvastatin
and pravastatin, in order to counteract the side effects resulting from
a dramatic CoQ10 deficiency in the human body.
To this day Merck has made no use of this patent, while simultaneously
preventing other companies from producing such medications.
Liver damage could also be counteracted by the administration of CoQ10.
Once again, Merck is blocking this via an additional patent (US
Patent No. 4,929,437).
This use of patents by the pharmaceutical industry to suppress vital
health information on a natural substance is only the tip of the iceberg.
The pharmaceutical industry now aims, acting under the guise of the
international Codex Alimentarius Commission, to impose worldwide bans
on all health information on natural substances. As this example using
anti-cholesterol drugs shows, millions of human lives would be put at
risk in the interests of the billion-pound profits of a handful of pharmaceutical
combines. |
